Resource Logo
NLM AIDSLINE

[Treatment and primary and secondary prevention of cerebral toxoplasmosis in patients with HIV infection]




 

Enferm Infecc Microbiol Clin. 1994 Mar;12(3):158-63. Unique Identifier :

Anticonvulsants/THERAPEUTIC USE Antiprotozoal Agents/ADMINISTRATION & DOSAGE/PHARMACOKINETICS/ *THERAPEUTIC USE AIDS-Related Opportunistic Infections/DRUG THERAPY/*PREVENTION & CONTROL/PARASITOLOGY Human *HIV Infections Recurrence Seizures/ETIOLOGY/PREVENTION & CONTROL Toxoplasmosis, Cerebral/COMPLICATIONS/DRUG THERAPY/*PREVENTION & CONTROL JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL



 




Information in this article was accurate in September 30, 1994. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.